Cargando…

The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology

SIMPLE SUMMARY: The endocannabinoid system (ECS) is a complex signaling pathway system involved in the regulation of multiple functions in both normal tissues and cancer. Δ9-tetrahydrocannabinol and cannabidiol are plant-derived cannabinoids that possess some efficacy against adult cancer, in part v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andradas, Clara, Truong, Alexandra, Byrne, Jacob, Endersby, Raelene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796497/ https://www.ncbi.nlm.nih.gov/pubmed/33466435 http://dx.doi.org/10.3390/cancers13010157

Ejemplares similares

Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma
por: Andradas, Clara, et al.
Publicado: (2021)

BIOL-12. ENHANCING IMMUNE-MEDIATED TUMOR CONTROL IN MURINE MODELS OF GROUP 3 MEDULLOBLASTOMA
por: Abbas, Zahra, et al.
Publicado: (2023)

Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma
por: Buck, Jessica, et al.
Publicado: (2021)

Cannabinoids as anticancer drugs: current status of preclinical research
por: Hinz, Burkhard, et al.
Publicado: (2022)

Long-term outcomes of symptomatic optic pathway glioma: 32-year experience at a single Western Australian tertiary pediatric oncology center
por: Rajagopal, Revathi, et al.
Publicado: (2023)

A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors
por: Endersby, Raelene, et al.
Publicado: (2018)

Potential Role of Garcinol as an Anticancer Agent
por: Saadat, Nadia, et al.
Publicado: (2012)

MOMC-5. Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
por: Genovesi, Laura, et al.
Publicado: (2021)

Editorial: Bench to bedside: translating pre-clinical research into clinical trials for childhood brain tumors
por: Endersby, Raelene, et al.
Publicado: (2023)

Defining the molecular features of radiation-induced glioma: A systematic review and meta-analysis
por: Whitehouse, Jacqueline P, et al.
Publicado: (2021)

Role of Cannabinoids in Obesity
por: Rossi, Francesca, et al.
Publicado: (2018)

Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
por: Giacoppo, Sabrina, et al.
Publicado: (2014)

Flavonoids as Anticancer Agents
por: Kopustinskiene, Dalia M., et al.
Publicado: (2020)

Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
por: Albini, Adriana, et al.
Publicado: (2010)

Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence
por: Dzierżanowski, Tomasz
Publicado: (2019)

The Role of Cannabinoids in the Setting of Cirrhosis
por: Dibba, Pratima, et al.
Publicado: (2018)

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
por: Caffarel, María M, et al.
Publicado: (2010)

Cannabinoids as therapeutic agents in cancer: current status and future implications
por: Chakravarti, Bandana, et al.
Publicado: (2014)

Equivalent doses for anticancer agents used in pediatric oncology: A literature review and evaluation of a novel approach for conversion factors
por: Ressing, Meike, et al.
Publicado: (2023)

Anticancer Agents Targeted to Sirtuins
por: Kozako, Tomohiro, et al.
Publicado: (2014)

Thiadiazole derivatives as anticancer agents
por: Szeliga, Monika
Publicado: (2020)

Polyoxometalates Impact as Anticancer Agents
por: Carvalho, Fátima, et al.
Publicado: (2023)

Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review
por: Trac, Judy, et al.
Publicado: (2021)

Pediatric Oncology
por: Morris-Jones, P. H.
Publicado: (1981)

Benzothiazole derivatives as anticancer agents
por: Irfan, Ali, et al.
Publicado: (2019)

Monofunctional Platinum(II) Anticancer Agents
por: Jin, Suxing, et al.
Publicado: (2021)

Phenformin as an Anticancer Agent: Challenges and Prospects
por: García Rubiño, Mª Eugenia, et al.
Publicado: (2019)

Anti-Inflammatory Drugs as Anticancer Agents
por: Zappavigna, Silvia, et al.
Publicado: (2020)

Lithium: A Promising Anticancer Agent
por: Villegas-Vázquez, Edgar Yebrán, et al.
Publicado: (2023)

Cannabinoids: from pot to lab
por: Papaseit, Esther, et al.
Publicado: (2018)

Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists
por: Butler, Helen, et al.
Publicado: (2009)

Cannabinoids and Cannabinoid Receptors: The Story so Far
por: Shahbazi, Fred, et al.
Publicado: (2020)

The Role of Cannabinoid Receptors in the Descending Modulation of Pain
por: Palazzo, Enza, et al.
Publicado: (2010)

The role of cannabinoids in neurodevelopmental disorders of children and adolescents
por: de Freitas, Francisca Dias, et al.
Publicado: (2022)

Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome
por: Tilemann, Lisa M., et al.
Publicado: (2018)

Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology
por: Abdelgawad, Ibrahim Y., et al.
Publicado: (2019)

Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients
por: Tay, Nicolette, et al.
Publicado: (2022)

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging
por: Thian, Yee Liang, et al.
Publicado: (2013)

Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis
por: Belgers, Vera, et al.
Publicado: (2023)

From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress
por: Dewdney, Brittany, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s03edm4m4c9v7ashdgmhuhbbjq